A European Regulatory Panel Voted Against Approval of Biogen's Alzheimer's Disease Drug ... - Latest Tweet by Reuters

A European regulatory panel voted against approval of Biogen's Alzheimer's disease drug Aduhelm. The drug was approved by U.S. regulators earlier this year despite mixed data, and after an independent panel to the U.S. FDA voted against the approval https://t.co/fV7Bq9LzHp pic.twitter.com/X8NFin07TJ— Reuters (@Reuters) November 17, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)